Cargando…
Antitumor Effects of a Novel Chromosome Region Maintenance 1 (CRM1) Inhibitor on Non-Small Cell Lung Cancer Cells In Vitro and in Mouse Tumor Xenografts
BACKGROUND: Chromosome Region Maintenance 1 (CRM1) is a nuclear exporter and its inhibitor has anti-tumor activity in various cancers. This study assessed the therapeutic efficiency of the novel CRM1 inhibitor KPT-185 on non-small cell lung cancer (NSCLC). METHODS: NSCLC cell lines were treated with...
Autores principales: | Wang, Shuai, Han, Xiaohong, Wang, Jianfei, Yao, Jiarui, Shi, Yuankai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3942386/ https://www.ncbi.nlm.nih.gov/pubmed/24595136 http://dx.doi.org/10.1371/journal.pone.0089848 |
Ejemplares similares
-
The abnormal expression of chromosomal region maintenance 1 (CRM1)-survivin axis in ovarian cancer and its related mechanisms regulating proliferation and apoptosis of ovarian cancer cells
por: Zhang, Jing, et al.
Publicado: (2022) -
Antitumor activity of histone deacetylase inhibitor chidamide alone or in combination with epidermal growth factor receptor tyrosine kinase inhibitor icotinib in NSCLC
por: Zhang, Ningning, et al.
Publicado: (2019) -
CRM1 Inhibitors for Antiviral Therapy
por: Mathew, Cynthia, et al.
Publicado: (2017) -
Small Molecule Inhibitors of CRM1
por: Ferreira, Bibiana I., et al.
Publicado: (2020) -
Oncolytic viro-chemotherapy exhibits antitumor effect in laryngeal squamous cell carcinoma cells and mouse xenografts
por: Wang, Yigang, et al.
Publicado: (2019)